Mankind Pharma shares skid 4% amid block deal buzz Three private equity funds, namely Chrys Capital, Capital Group, and Everbridge Partners, were reportedly looking to sell stakes worth $592 million in Mankind Pharma via the block deal. By Chitranjan Kumar
